GME
GameStop Corp.
GME offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MCRI
Monarch Casino & Resort, Inc.
MCRI has the edge over GME overall, supported by lower modeled downside and stronger modeled upside.
GME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
MCRI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
MCRI's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
GME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.62 | — |
| Cheap | 18x | $27.96 | +9.1% |
| Forward | 38x | $25.62 | — |
| Fair | 43x | $66.84 | +161% |
| Expensive | 252x | $388 | +1414% |
Historical ranges are pointers, not guarantees.
GME has the edge over MCRI in the historical PE scenario, which offers more potential upside but is not a forecast.
MCRI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $99.43 | -10% |
| Forward | 16x | $111 | — |
| Current | 18x | $111 | — |
| Fair | 19x | $122 | +10% |
| Expensive | 28x | $176 | +58% |
Historical ranges are pointers, not guarantees.
MCRI's PE is in its fair range at 18x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
GME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GME's earnings and revenue to decline, with profitability weakening.
MCRI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
MCRI has the edge over GME on the outlook, with more favorable valuation and earnings expectations.
GME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -56% |
| Q3 2026 | $1.54 | +93% |
| Q2 2026 | $1.34 | +153% |
| Q1 2026 | $0.77 | +133% |
| Q4 2025 | $0.89 | +394% |
| Q3 2025 | $0.80 | +515% |
| Q2 2025 | $0.53 | +563% |
| Q1 2025 | $0.33 | +1550% |
| Q4 2024 | $0.18 | +$0.21 |
GME has the edge over MCRI on earnings, with more consistent year-over-year improvement.
MCRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.99 | +11% |
| Q3 2026 | $6.31 | +42% |
| Q2 2026 | $6.24 | +48% |
| Q1 2026 | $5.90 | +49% |
| Q4 2025 | $5.43 | +41% |
| Q3 2025 | $4.43 | -2% |
| Q2 2025 | $4.21 | -1.6% |
| Q1 2025 | $3.96 | -6.4% |
| Q4 2024 | $3.84 | -8.6% |
MCRI earned $6.31 per share over the past year, up 42% from the year before.
GME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790.2M | -19% |
| Q2 2026 | $835.3M | +14% |
| Q1 2026 | $1.1B | -14% |
| Q4 2025 | $821M | -4.6% |
| Q3 2025 | $972.2M | +22% |
| Q2 2025 | $732.4M | -17% |
| Q1 2025 | $1.3B | -28% |
| Q4 2024 | $860.3M | -20% |
GME's revenue has slid since its 2022 peak: $790M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +13 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 12% | +6 points |
| Q4 2025 | 5% | +8.9 points |
| Q3 2025 | 6.8% | +9.6 points |
| Q2 2025 | -1.5% | +4.3 points |
| Q1 2025 | 6.2% | +3.1 points |
| Q4 2024 | -3.9% | -2.5 points |
GME's operating margin was 20% last quarter, up 13 points from the same quarter a year ago, near the top of its range since 2019.
MCRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $146.3M | +2.4% |
| Q2 2026 | $142.6M | +4.2% |
| Q1 2026 | $136.6M | +8.9% |
| Q4 2025 | $140M | +4.1% |
| Q3 2025 | $142.8M | +3.6% |
| Q2 2025 | $136.9M | +6.8% |
| Q1 2025 | $125.4M | +3.1% |
| Q4 2024 | $134.5M | +4.9% |
MCRI has the edge over GME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | +1.5 points |
| Q2 2026 | 27% | +1.6 points |
| Q1 2026 | 26% | +5.4 points |
| Q4 2025 | 21% | +18 points |
| Q3 2025 | 27% | +1.1 points |
| Q2 2025 | 25% | +2.5 points |
| Q1 2025 | 20% | +0.6 points |
| Q4 2024 | 2.9% | -17 points |
MCRI has the edge over GME on profitability, with a higher operating margin.
GME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | -46% |
| Q2 2026 | $332.9M | +76% |
| Q1 2026 | $187.4M | +18% |
| Q4 2025 | $107M | +435% |
| Q3 2025 | $113.3M | +73% |
| Q2 2025 | $189.6M | +$304.3M |
| Q1 2025 | $158.8M | +$177.5M |
| Q4 2024 | $20M | +80% |
GME has the edge over MCRI on cash flow, with more consistent year-over-year improvement.
MCRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $41.9M | -22% |
| Q2 2026 | $25.6M | -1.7% |
| Q1 2026 | $43M | +158% |
| Q4 2025 | $32.2M | +23% |
| Q3 2025 | $53.5M | +51% |
| Q2 2025 | $26M | +138% |
| Q1 2025 | $16.6M | -19% |
| Q4 2024 | $26.2M | +20% |
MCRI generated $143M in free cash flow over the past year, up 16% from the year before.
GME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +300K shares |
| 1 year | +8.4% | +46.1M shares |
| 3 years | +94% | +288M shares |
| 5 years | +104% | +302M shares |
| Available history | +80% | +264M shares |
GME has 593M diluted shares, up 8.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q1 2020 | $21.8M |
| Q4 2019 | $114M |
MCRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -113K shares |
| 1 year | -3.1% | -588K shares |
| 3 years | -7.4% | -1.5M shares |
| 5 years | -6.6% | -1.3M shares |
| Available history | -2.9% | -536K shares |
MCRI has the edge over GME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $37.4M |
| Q2 2026 | $212,000 |
| Q1 2026 | $17.7M |
| Q4 2025 | $41.4M |
| Q3 2025 | $11.3M |
| Q4 2024 | $63,000 |
| Q3 2024 | $9.7M |
MCRI spent $97M buying back its own shares over the past year.
GME Net Leverage
MCRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
MCRI has more cash than debt.
GME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 68.5 | Neutral |
GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
MCRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.4 | Neutral |
| Stochastic | 13.8 | Oversold |
MCRI's weekly RSI is 41 (neutral) and its Stochastic is 14 (oversold).
GME PE vs Consumer Cyclical Sector
| Metric | GME | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7.7% below |
| PE % | 15 | 47 | 32 pts below |
GME has the edge over MCRI on valuation relative to its sector.
MCRI PE vs Consumer Cyclical Sector
| Metric | MCRI | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 2.6% below |
| PE % | 33 | 47 | 14 pts below |
MCRI is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
GME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.2 | 1.8% above |
| 20 week MA | $22.4 | 15% above |
| 50 week MA | $22.6 | 13% above |
| 100 week MA | $24.0 | 7% above |
| 200 week MA | $21.8 | 17% above |
GME has the edge over MCRI on trend strength, trading above more of its moving averages.
MCRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $113.3 | 2.1% below |
| 20 week MA | $119.4 | 7.2% below |
| 50 week MA | $110.6 | 0.2% above |
| 100 week MA | $100.0 | 11% above |
| 200 week MA | $85.4 | 30% above |
MCRI has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 30% above its 200-week average.
GME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.48 | $5.04 | +241% |
| 2021 | $5.04 | $38.0 | +655% |
| 2022 | $38.0 | $20.1 | -47% |
| 2023 | $20.1 | $17.5 | -13% |
| 2024 | $17.5 | $32.2 | +84% |
| 2025 | $32.2 | $21.1 | -35% |
| 2026 YTD | $21.1 | $25.6 | +21% |
GME has the edge over MCRI on returns for 2026, with the stronger performance.
MCRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.1 | $59.5 | +24% |
| 2021 | $59.5 | $73.5 | +24% |
| 2022 | $73.5 | $77.0 | +4.7% |
| 2023 | $77.0 | $69.2 | -10% |
| 2024 | $69.2 | $78.1 | +13% |
| 2025 | $78.1 | $98.3 | +26% |
| 2026 YTD | $98.3 | $110.8 | +13% |
MCRI has finished higher in five of the last six years. It's up 13% so far in 2026.